Linked e-resources
Details
Table of Contents
I. Injectable OrthoBiologics: Formulations and Rationale 1. Bone marrow-derived cultured stromal cells and Bone Marrow Concentrate
2. Adipose-derived cultured stromal cells and Stromal Vascular Fraction from adipose tissue
3. Synovial-derived cultured stromal cells
4. Amniotic, Placenta, and Umbilical cord-derived cultured stromal cells
5. Allogeneic cells: pros and cons
6. Steroid hormones
7. Cytokines, chemokines, alpha-2-macroglobulin, growth factors
8. Platelet-rich plasma: leucocyte-rich, leukocyte-poor, autologous conditioned serum, autologous protein solution
9. Amniotic tissue extract, placenta tissue extract
10. Extracellular vesicles (exosomes)
II. Injectable OrthoBiolologics: evaluation methods and results based on pathology and anatomy
11. Rotator cuff tendinopathy: cell therapy
12. Rotator cuff tendinopathy: biologics
13. Tennis elbow: cell therapy
14. Tennis elbow: cell therapy biologics
15. Patellar tendinopathy: cell therapy
16. Patellar tendinopathy: biologics
17. Achilles tendinopathy: cell therapy
18. Achilles tendinopathy: biologics
19. Plantar Fasciitis: cell therapy
20. Plantar Fasciitis: biologics
21. Ligament lesions: cell therapy
22. Ligament lesions: biologics
23. Meniscal lesions: cell therapy
24. Meniscal lesions: biologics
25. Muscle lesions: cell therapy
26. Muscle lesions: biologics
27. Fractures (incl. Nonunions): cell therapy
28. Fractures (incl. Nonunions): biologics
29. Cartilage lesions and Osteoarthritis of the knee: cell therapy
30. Cartilage lesions and Osteoarthritis of the knee: biologics
31. Cartilage lesions and Osteoarthritis of the hip and ankle: cell therapy
32. Cartilage lesions and Osteoarthritis of the hip and ankle: biologics
III. Future directions 33. Pluripotent stem cells: Embryonic/Fetal stem cells and induced pluripotent stem (iPS) cells
34. Gene therapy
35. Stimulation of the intrinsic stromal cell niche
36 Conclusions.
2. Adipose-derived cultured stromal cells and Stromal Vascular Fraction from adipose tissue
3. Synovial-derived cultured stromal cells
4. Amniotic, Placenta, and Umbilical cord-derived cultured stromal cells
5. Allogeneic cells: pros and cons
6. Steroid hormones
7. Cytokines, chemokines, alpha-2-macroglobulin, growth factors
8. Platelet-rich plasma: leucocyte-rich, leukocyte-poor, autologous conditioned serum, autologous protein solution
9. Amniotic tissue extract, placenta tissue extract
10. Extracellular vesicles (exosomes)
II. Injectable OrthoBiolologics: evaluation methods and results based on pathology and anatomy
11. Rotator cuff tendinopathy: cell therapy
12. Rotator cuff tendinopathy: biologics
13. Tennis elbow: cell therapy
14. Tennis elbow: cell therapy biologics
15. Patellar tendinopathy: cell therapy
16. Patellar tendinopathy: biologics
17. Achilles tendinopathy: cell therapy
18. Achilles tendinopathy: biologics
19. Plantar Fasciitis: cell therapy
20. Plantar Fasciitis: biologics
21. Ligament lesions: cell therapy
22. Ligament lesions: biologics
23. Meniscal lesions: cell therapy
24. Meniscal lesions: biologics
25. Muscle lesions: cell therapy
26. Muscle lesions: biologics
27. Fractures (incl. Nonunions): cell therapy
28. Fractures (incl. Nonunions): biologics
29. Cartilage lesions and Osteoarthritis of the knee: cell therapy
30. Cartilage lesions and Osteoarthritis of the knee: biologics
31. Cartilage lesions and Osteoarthritis of the hip and ankle: cell therapy
32. Cartilage lesions and Osteoarthritis of the hip and ankle: biologics
III. Future directions 33. Pluripotent stem cells: Embryonic/Fetal stem cells and induced pluripotent stem (iPS) cells
34. Gene therapy
35. Stimulation of the intrinsic stromal cell niche
36 Conclusions.